Patents by Inventor Hyun Jung Kang

Hyun Jung Kang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10650816
    Abstract: An artificial intelligence voice interactive system may provide various services to a user in response to a voice command. The system may perform at least one of: receiving user speech from a user; transmitting the received user speech to the central server; receiving at least one of control signals and audio and video answers, which are generated based on an analysis and interpretation result of the user speech, from at least one of the central server, the internal service servers, and the external service servers; and outputting the received audio and video answers through at least one of speakers and a display coupled to the user interactive device and controlling at least one device according to the control signals.
    Type: Grant
    Filed: January 16, 2018
    Date of Patent: May 12, 2020
    Assignee: KT CORPORATION
    Inventors: Sang-Wook Lee, Hyun-Jung Kang, Sun-Jong Kwon, Mi-Hee Kim, Jin-Han Kim, Gyu-Tae Baek, Joo-Won Sung, Kyeong-Jin Oh, Jin-Young Oh, Ji-Hui Im, Du-Seong Chang, Won-Seock Choi
  • Publication number: 20180322870
    Abstract: An artificial intelligence voice interactive system may provide various services to a user in response to a voice command.
    Type: Application
    Filed: January 16, 2018
    Publication date: November 8, 2018
    Applicant: KT CORPORATION
    Inventors: Sang-Wook LEE, Hyun-Jung KANG, Sun-Jong KWON, Mi-Hee KIM, Jin-Han KIM, Gyu-Tae BAEK, Joo-Won SUNG, Kyeong-Jin OH, Jin-Young OH, Ji-Hui IM, Du-Seong CHANG, Won-Seock CHOI
  • Patent number: 8268316
    Abstract: Disclosed is a monoclonal antibody having very high affinity to anthrax toxin and potent toxin-neutralizing activity. Also disclosed are a composition for neutralizing anthrax toxin comprising the antibody and a kit for detecting anthrax toxin.
    Type: Grant
    Filed: March 10, 2006
    Date of Patent: September 18, 2012
    Assignee: Aprogen, Inc
    Inventors: Hyo Jeong Hong, Kyung Soo Inn, Nam Kyu Lim, Jung Whan Kim, Keun Soo Kim, Sang Yoon Lee, Se Yeon Kim, Hyun Jung Kang, Mee Sook Oh
  • Publication number: 20110117104
    Abstract: Disclosed is a monoclonal antibody having very high affinity to anthrax toxin and potent toxin-neutralizing activity. Also disclosed are a composition for neutralizing anthrax toxin comprising the antibody and a kit for detecting anthrax toxin.
    Type: Application
    Filed: March 10, 2006
    Publication date: May 19, 2011
    Applicant: Aprogen Inc.
    Inventors: Hyo Jeong Hong, Kyung Soo Inn, Nam Kyu Lim, Jung Whan Kim, Keun Soo Kim, Sang Yoon Lee, Se Yeon Kim, Hyun Jung Kang, Mee Sook Oh
  • Publication number: 20070154820
    Abstract: A photosensitive resin composition suitable for the production of a light-shielding black matrix for use in a liquid crystal display is disclosed. The photosensitive resin composition includes a cardo binder resin and a carboxyl group-containing polyfunctional monomer and exhibits superior physical properties, such as heat resistance, chemical resistance, development margin, developability and adhesive properties. Further disclosed is a black matrix produced using the photosensitive resin composition. The black matrix has superior physical properties, including heat resistance, chemical resistance, development margin and adhesive properties. Particularly, since the black matrix has excellent developability with an alkaline solution, it contains no undissolved material of the composition in radiation-unexposed portions.
    Type: Application
    Filed: August 28, 2006
    Publication date: July 5, 2007
    Inventors: Hyun Jung Kang, Choun Woo Lee, Hee Young Oh, Cheon Seok Lee
  • Patent number: 7094913
    Abstract: The present invention relates to a synthesis of a 7-membered carbocyclic compound having diexomethylene groups, more particularly to a synthesis of a 7-membered carbocyclic compound having diexomethylene groups, a novel compound having the structure represented by the following Chemical Formula 1, from trimethylsilanylmethyl-allenol derivative by the intramolecular Prins cyclization using Lewis acid. The 7-membered carbocyclic compound is a useful intermediate for synthesis of other multicyclic compounds. In Chemical Formula 1, R1 is a C1 to C6 alkyl group, and R2 and R3 is respectively a hydrogen atom, or R1, R2 and R3 may be connected with neighboring substituents to form a 5 to 10-membered aliphatic or aromatic ring.
    Type: Grant
    Filed: April 14, 2004
    Date of Patent: August 22, 2006
    Assignee: Korea Institute of Science and Technology
    Inventors: Yong Seo Cho, Moon Ho Chang, Hun Yeong Koh, Ae Nim Pae, Hyun Jung Kang
  • Patent number: 6872840
    Abstract: The present invention relates to a synthesis of an 8-membered carbocyclic compound having diexomethylene groups, more particularly to a synthesis of an 8-membered carbocyclic compound having diexomethylene groups, a novel compound having the structure represented by the following Chemical Formula 1, from trimethylsilanylmethyl-allenol derivative by the intramolecular Prins cyclization using Lewis acid. The 8-membered carbocyclic compound is a useful intermediate for synthesis of other multicarbocyclic compounds. In Chemical Formula 1, R1 is a phenyl group, and R2 and R3 is a hydrogen atom, or R1, R2 and R3 may be connected with neighboring substituents to form a 5 to 10-membered aliphatic or aromatic ring.
    Type: Grant
    Filed: April 14, 2004
    Date of Patent: March 29, 2005
    Assignee: Korea Institute of Science And Technology
    Inventors: Yong Seo Cho, Moon Ho Chang, Hun Yeong Koh, Ae Nim Pae, Hyun Jung Kang